Back to results
CompletedPhase 2

GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer

NCT00068588

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California Davis Cancer Center

Sacramento, California, United States

View on ClinicalTrials.gov
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer — TrialFind